Stem cell therapy for ALS (amyotrophic lateral sclerosis) in EDNA Wellness

Stem cell therapy for ALS at EDNA Wellness in Bangkok, Thailand, provides a specialized approach using umbilical cord-derived mesenchymal stem cells (UC-MSCs). This investigational therapy focuses on creating a supportive environment for nerves through anti-inflammatory and neurotrophic signaling. The program is led by Dr. Pongwat Polpong, a board-certified neurosurgeon who manages treatments produced under strict laboratory standards.

Advanced Cell Therapy Protocol

The clinic uses allogeneic UC-MSCs harvested from the Wharton’s jelly of donated umbilical cords. These cells are processed in a laboratory with Good Manufacturing Practice (GMP) certification and oversight from the Thailand Institute of Scientific and Technological Research. This process helps maintain high standards for cell quality and traceability. The therapy works by releasing signals to support the neurological environment rather than replacing lost motor neurons.

Individualized Patient Care

Every patient undergoes a thorough evaluation before starting treatment. This includes a review of functional status, breathing capacity, and current medications. Dr. Pongwat Polpong and his team use these assessments to determine the most appropriate administration route and dosing. While not a cure, this supportive therapy is integrated into a broader multidisciplinary plan that includes respiratory and nutritional support.

Expected Timeline and Outcomes

Treatment at the clinic is personalized, but general neurological protocols often include the following features:

• Dosing: IV infusions typically range from 1 to 2 million cells per kilogram.
• Recovery: Effects usually develop over several weeks or months.
• Benefit: Maximum improvements are often observed within 1 to 3 months.
• Duration: Benefits may last between 6 and 12 months.
• Follow-up: The clinic provides 24-hour support and scheduled appointments after the procedure.

Specialized Facility Standards

EDNA Wellness is a surgeon-led center located near Bangkok Hospital. The facility holds ISO 9001:2015 and ISO/IEC 17025:2017 certifications, focusing exclusively on regenerative medicine for neurological and orthopedic conditions. Because ALS is a progressive disease, treatments are often repeated every 6 to 12 months based on how the patient responds to the initial therapy.

To learn more about your eligibility for this supportive therapy, you can leave a request on Bookimed for a case review.